Today: 7 February 2026
Subscribe

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

New York, Jan 5, 2026, 14:29 EST — Regular session Fabrinet (NYSE:FN) shares fell about 6.7% on Monday, bucking a rise in the broader market. The stock was down $32.06 at $447.36 by 2:29 p.m. EST, after swinging between $490.18 and $440.00. The S&P 500 and Nasdaq were up about 0.7% and 0.8%, respectively. The move matters because Fabrinet sits deep in the hardware supply chain, providing optical packaging — the assembly and testing of optical components — and other precision manufacturing services for complex products. That leaves the stock sensitive to shifts in demand from equipment makers serving telecom
5 January 2026
·······
IREN stock jumps 11% as bitcoin rallies — what’s driving Nasdaq: IREN today

IREN stock jumps 11% as bitcoin rallies — what’s driving Nasdaq: IREN today

NEW YORK, Jan 5, 2026, 14:26 EST — Regular session IREN Limited shares climbed about 11% on Monday afternoon, outpacing the broader market as bitcoin pushed higher and traders returned to crypto-linked equities. The stock was last up at $47.36. The move matters because IREN still trades as a high-beta proxy for bitcoin prices, even as it markets itself as an AI infrastructure supplier with large power-backed data center sites. That mix can amplify swings when risk appetite shifts. GlobeNewswire Broader U.S. equities were also firmer, and “we’re seeing a risk on mood,” Steve Sosnick, chief market analyst at Interactive
5 January 2026
···········
Natural gas price stock UNG slides as Henry Hub futures tumble 5% on warm U.S. outlook

Natural gas price stock UNG slides as Henry Hub futures tumble 5% on warm U.S. outlook

New York, January 5, 2026, 14:17 EST — Regular session Shares of the United States Natural Gas Fund (UNG) fell about 4% on Monday as benchmark U.S. natural gas futures dropped more than 5% in winter trade. The NYSE Arca-listed fund was down 4.1% at $11.57, while the February Henry Hub contract fell 5.5% to $3.419 per million British thermal units (mmBtu), a standard unit for gas pricing. CME Group The move matters now because the market is still in the heart of the heating season, when a few degrees of temperature change can quickly rewrite demand expectations. Meteorologists are
5 January 2026
········
Sunrun stock slides as RUN lags solar peers with jobs report, Goldman conference in focus

Sunrun stock slides as RUN lags solar peers with jobs report, Goldman conference in focus

New York, Jan 5, 2026, 14:26 EST — Regular session Sunrun Inc shares fell 5.6% on Monday, a sharp underperformer in U.S. solar, as investors weighed fresh U.S. economic data and looked ahead to a key jobs report later this week. The stock was down $1.08 at $18.36 in afternoon trade. The move matters because Sunrun’s rooftop solar business leans heavily on financing, and shifts in interest-rate expectations can quickly change customer economics and investor appetite for the sector. Traders were also scanning for any read-through on demand and pricing as the first full week of 2026 gets underway. Reuters
5 January 2026
····
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

New York, January 5, 2026, 14:21 EST — Regular session Shares of Viking Therapeutics (VKTX) slid 9.9% to $31.93 in afternoon trading on Monday as obesity-drug stocks reacted to Novo Nordisk’s U.S. launch of a Wegovy weight-loss pill. Novo’s U.S.-listed shares rose 5.1%, while Eli Lilly fell 3.9% and the SPDR S&P Biotech ETF dropped 2.2%. The move highlights how sensitive obesity-drug developers remain to pricing signals from the market leaders. Viking has no approved products, so changes in expected pricing can hit the stock as hard as trial data. Direct-to-consumer discounts are also changing how investors think about margins
5 January 2026
······
Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus

Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus

New York, January 5, 2026, 1:09 PM ET — Regular session Wave Life Sciences Ltd shares fell $1.34, or 8.4%, to $14.61 in afternoon trade on Monday, extending a sharp pullback in the clinical-stage biotech even as the company flagged an investor-conference appearance next week. The move matters because the J.P. Morgan Healthcare Conference often sets the tone for biotech investing early in the year, and Wave’s stock has become closely tethered to expectations for updates on its obesity program and financing needs. Biotech lagged more broadly, with the SPDR S&P Biotech ETF down about 2.1% and the iShares Nasdaq
5 January 2026
····
IBM stock climbs as Jefferies turns bullish and lifts target to $360

IBM stock climbs as Jefferies turns bullish and lifts target to $360

New York, Jan 5, 2026, 14:09 (EST) — Regular session International Business Machines (IBM.N) shares rose 1.6% to $296.24 in afternoon trading on Monday, after Jefferies upgraded the stock and RBC Capital raised its price target. The shares traded between $293.00 and $299.18 on the day. The upbeat calls land as Wall Street starts to reset 2026 expectations for enterprise software and spending on artificial intelligence tools. For IBM, the next test is whether its software and hybrid-cloud businesses can keep growing fast enough to justify a premium multiple. Jefferies upgraded IBM to Buy from Hold and raised its price
5 January 2026
·····
D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

New York, Jan 5, 2026, 14:02 EST — Regular session Shares of D-Wave Quantum Inc. (QBTS) rose nearly 10% on Monday, lifting the quantum-computing stock back toward $31 as traders tracked an uptick in options activity ahead of this week’s CES events. The rally matters because QBTS has become a bellwether for risk appetite in the thinly traded “quantum” corner of the market, where sentiment can turn on conference demos and headlines more quickly than on quarterly fundamentals. With CES days away, investors are watching for any customer wins, partnerships or product-readout details that can be tied to revenue, not
5 January 2026
·······
Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

New York, Jan 5, 2026, 13:05 EST — Regular session Gulfport Energy Corporation shares fell 8.7% on Monday after Wolfe Research analyst Carlos Escalante cut the U.S. gas producer to Peer Perform from Outperform. The stock traded at $188.26 after swinging between $209.00 and $187.93. GuruFocus The call matters now because investors have been repricing gas-linked cash flows as the fuel’s latest pullback deepens. U.S. natural gas fell about 3.5% to $3.49 per million British thermal units, according to TradingEconomics data. Trading Economics Escalante wrote that Wolfe lowered its long-term U.S. gas price forecast by 25 cents to $4.00 per
5 January 2026
·····
GE Aerospace stock hits fresh high as Wall Street sizes up the next earnings test

GE Aerospace stock hits fresh high as Wall Street sizes up the next earnings test

New York, Jan 5, 2026, 14:02 EST — Regular session GE Aerospace shares rose $6.05, or 1.9%, to $326.80 in afternoon trading on Monday. The stock touched $328.54 earlier after opening at $328.26, and has traded between $320.96 and $328.54 with about 2.7 million shares changing hands. The move keeps GE stock near the top of a powerful run and puts the spotlight on the company’s next earnings update later this month. Investors want evidence that engine production is catching up and that service demand is still converting into cash at a time when airlines and manufacturers are leaning hard
5 January 2026
·····
SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

New York, Jan 5, 2026, 13:54 EST — Regular session SiTime Corp shares slid about 9% on Monday afternoon, reversing an earlier rise and wiping out a chunk of the timing-chip maker’s start-of-year gains. The Nasdaq-listed stock was down $33.46 at $336.50, after trading as high as $382 and as low as $333.33. The move matters because SiTime has become a high-beta way to play the semiconductor cycle, and investors are reassessing richly valued niche chip names as 2026 gets underway. A sharp intraday turn like Monday’s often signals fast money leaving crowded positions, even when the broader sector is
5 January 2026
·····
Nvidia stock slips ahead of CES 2026 keynote as Foxconn AI sales jump and Dalio flags bubble risk

Nvidia stock slips ahead of CES 2026 keynote as Foxconn AI sales jump and Dalio flags bubble risk

NEW YORK, Jan 5, 2026, 13:54 EST — Regular session Nvidia shares were down 0.5% on Monday as investors waited for CEO Jensen Huang to headline a CES press conference in Las Vegas at 4 p.m. ET, according to the conference schedule. The chipmaker has faced tougher questions from rivals and even large customers building their own artificial intelligence chips. Reuters The timing matters because Nvidia is the bellwether for AI hardware demand, and its comments can ripple across chipmakers, server builders and the big cloud companies writing the checks. After a strong 2025 for U.S. equities, traders have started
5 January 2026
····
1 … 915 916 917 918 919 … 2,711

Stock Market Today

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

7 February 2026
Vodafone shares rose 1.47% to 110.60p Friday, recovering part of Thursday’s 4.68% drop after a Q3 update. Group revenue climbed 6.5% to €10.5 billion, but Germany’s 0.7% service revenue growth missed some forecasts. Vodafone launched a new €500 million buyback tranche, bringing total buybacks since May to €3.5 billion. Investors remain focused on Germany’s pace and cash flow execution.
NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

7 February 2026
BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
Go toTop